InvestSMART

Optiscan Imaging Limited (ASX: OIL) - Announcements

Current share price for OIL : $0.155 0.005 (3.33%)+

ASX company news and announcements for Optiscan Imaging Limited (OIL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Optiscan Imaging Limited (OIL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Optiscan Imaging Limited (OIL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Optiscan Imaging Limited (OIL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$162 Amended Company Constitution 25 Nov 2022 1:06PM $0.100 $0.155 risen by 55%
$162 Results of Annual General Meeting 24 Nov 2022 3:16PM $0.100 $0.155 risen by 55%
$162 Optiscan Managing Director 2022 AGM Presentation 24 Nov 2022 10:59AM $0.115 $0.155 risen by 34.78%
$162 Optiscan Chairman's AGM Address 24 Nov 2022 10:51AM $0.115 $0.155 risen by 34.78%
$162 Statement pursuant to Listing Rule 4.7C.3 4 Nov 2022 10:57AM $0.130 $0.155 risen by 19.23%
$162 OIL September 2022 Quarterly Report and Appendix 4C 31 Oct 2022 1:48PM $0.145 $0.155 risen by 6.90%
$162 2022 AGM - Letter to Shareholders & Proxy Form 25 Oct 2022 6:26PM $0.150 $0.155 risen by 3.33%
$162 Notice of Annual General Meeting/Proxy Form 25 Oct 2022 6:15PM $0.150 $0.155 risen by 3.33%
$162 Proposed issue of securities - OIL 25 Oct 2022 8:59AM $0.140 $0.155 risen by 10.71%
$162 Optiscan Imaging Acquires Intellectual Property 25 Oct 2022 8:50AM $0.140 $0.155 risen by 10.71%
$162 Optiscan receives R&D tax incentive rebate 24 Oct 2022 9:33AM $0.125 $0.155 risen by 24%
$162 Annual General Meeting Date 6 Oct 2022 4:56PM $0.110 $0.155 risen by 40.91%
$162 Appendix 4G & Corporate Governance Statement 31 Aug 2022 6:50PM $0.110 $0.155 risen by 40.91%
$162 Appendix 4E and 2022 Annual Report 31 Aug 2022 6:40PM $0.110 $0.155 risen by 40.91%
$162 Optiscan Submits FDA 510(k) Application for InVivage Device 22 Aug 2022 9:34AM $0.120 $0.155 risen by 29.17%
$162 OIL June 2022 Quarterly Report and Appendix 4C 29 Jul 2022 2:51PM $0.125 $0.155 risen by 24%
$162 Change in substantial holding 28 Jul 2022 1:57PM $0.125 $0.155 risen by 24%
$162 Notification of cessation of securities - OIL 14 Jul 2022 2:50PM $0.099 $0.155 risen by 56.57%
$162 Section 708A Cleansing Notice 1 Jul 2022 4:23PM $0.100 $0.155 risen by 55%
$162 Application for quotation of securities - OIL 1 Jul 2022 4:20PM $0.100 $0.155 risen by 55%
$162 Strategic Distribution Partnership - Additional Information 28 Jun 2022 11:24AM $0.098 $0.155 risen by 58.16%
$162 Optiscan announces Strategic Distribution Partner for China 27 Jun 2022 8:29AM $0.096 $0.155 risen by 61.46%
$162 Optiscan to present at Head & Neck Cancer World Congress 20 Jun 2022 8:22AM $0.115 $0.155 risen by 34.78%
$162 Initial Director's Interest Notice 17 Jun 2022 12:08PM $0.115 $0.155 risen by 34.78%
$162 Appointment of Non-executive Director 14 Jun 2022 2:58PM $0.130 $0.155 risen by 19.23%

176 - 200 of 634 results

Page 8 of 26

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.